246 related articles for article (PubMed ID: 24918772)
21. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments.
Yermakova A; Mantis NJ
Toxicon; 2013 Sep; 72():29-34. PubMed ID: 23603317
[TBL] [Abstract][Full Text] [Related]
22. Immunity to ricin: fundamental insights into toxin-antibody interactions.
O'Hara JM; Yermakova A; Mantis NJ
Curr Top Microbiol Immunol; 2012; 357():209-41. PubMed ID: 22113742
[TBL] [Abstract][Full Text] [Related]
23. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).
O'Hara JM; Kasten-Jolly JC; Reynolds CE; Mantis NJ
Immunol Lett; 2014; 158(1-2):7-13. PubMed ID: 24269767
[TBL] [Abstract][Full Text] [Related]
24. Intracellular Neutralization of Ricin Toxin by Single-domain Antibodies Targeting the Active Site.
Rudolph MJ; Czajka TF; Davis SA; Thi Nguyen CM; Li XP; Tumer NE; Vance DJ; Mantis NJ
J Mol Biol; 2020 Feb; 432(4):1109-1125. PubMed ID: 31931008
[TBL] [Abstract][Full Text] [Related]
25. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins.
Czajka TF; Vance DJ; Davis S; Rudolph MJ; Mantis NJ
J Biol Chem; 2022 Apr; 298(4):101742. PubMed ID: 35182523
[TBL] [Abstract][Full Text] [Related]
26. Folding domains within the ricin toxin A subunit as targets of protective antibodies.
O'Hara JM; Neal LM; McCarthy EA; Kasten-Jolly JA; Brey RN; Mantis NJ
Vaccine; 2010 Oct; 28(43):7035-46. PubMed ID: 20727394
[TBL] [Abstract][Full Text] [Related]
27. Neutralising antibodies against ricin toxin.
Prigent J; Panigai L; Lamourette P; Sauvaire D; Devilliers K; Plaisance M; Volland H; Créminon C; Simon S
PLoS One; 2011; 6(5):e20166. PubMed ID: 21633505
[TBL] [Abstract][Full Text] [Related]
28. Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies.
Hu WG; Yin J; Chau D; Hu CC; Lillico D; Yu J; Negrych LM; Cherwonogrodzky JW
Biomed Res Int; 2013; 2013():471346. PubMed ID: 23484120
[TBL] [Abstract][Full Text] [Related]
29. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
[TBL] [Abstract][Full Text] [Related]
30. An intranasally administered monoclonal antibody cocktail abrogates ricin toxin-induced pulmonary tissue damage and inflammation.
Rong Y; Torres-Velez FJ; Ehrbar D; Doering J; Song R; Mantis NJ
Hum Vaccin Immunother; 2020 Apr; 16(4):793-807. PubMed ID: 31589555
[TBL] [Abstract][Full Text] [Related]
31. Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin's Enzymatic Subunit Interfere with Intracellular Toxin Transport.
Yermakova A; Klokk TI; O'Hara JM; Cole R; Sandvig K; Mantis NJ
Sci Rep; 2016 Mar; 6():22721. PubMed ID: 26949061
[TBL] [Abstract][Full Text] [Related]
32. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.
Neal LM; O'Hara J; Brey RN; Mantis NJ
Infect Immun; 2010 Jan; 78(1):552-61. PubMed ID: 19858297
[TBL] [Abstract][Full Text] [Related]
33. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
[TBL] [Abstract][Full Text] [Related]
34. Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies.
Legler PM; Compton JR; Hale ML; Anderson GP; Olson MA; Millard CB; Goldman ER
MAbs; 2017 Jan; 9(1):43-57. PubMed ID: 27660893
[TBL] [Abstract][Full Text] [Related]
35. A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication.
Rong Y; Pauly M; Guthals A; Pham H; Ehrbar D; Zeitlin L; Mantis NJ
Toxins (Basel); 2020 Mar; 12(4):. PubMed ID: 32235318
[TBL] [Abstract][Full Text] [Related]
36. A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin.
Guo JW; Shen BF; Feng JN; Sun YX; Yu M; Hu MR
Hybridoma (Larchmt); 2005 Oct; 24(5):263-6. PubMed ID: 16225427
[TBL] [Abstract][Full Text] [Related]
37. A Collection of Single-Domain Antibodies that Crowd Ricin Toxin's Active Site.
Angalakurthi SK; Vance DJ; Rong Y; Nguyen CMT; Rudolph MJ; Volkin D; Middaugh CR; Weis DD; Mantis NJ
Antibodies (Basel); 2018 Dec; 7(4):. PubMed ID: 30775035
[TBL] [Abstract][Full Text] [Related]
38. Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA.
Neal LM; McCarthy EA; Morris CR; Mantis NJ
Vaccine; 2011 Jan; 29(4):681-9. PubMed ID: 21115050
[TBL] [Abstract][Full Text] [Related]
39. Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized.
Song K; Mize RR; Marrero L; Corti M; Kirk JM; Pincus SH
PLoS One; 2013; 8(4):e62417. PubMed ID: 23638075
[TBL] [Abstract][Full Text] [Related]
40. Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
Embleton MJ; Charleston A; Robins RA; Pimm MV; Baldwin RW
Br J Cancer; 1991 May; 63(5):670-4. PubMed ID: 2039690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
